IN line with the directive of President Ferdinand Marcos Jr. to prioritize strengthening the country’s education sector, Department of Budget and Management (DBM) Secretary Amenah Pangandaman approved ...

It’s been eight months since I was sworn into office, and nine months since you, the people of Ghana, went to the polls and ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.

YolTech Therapeutics, a clinical-stage biotech company pioneering in vivo genome editing therapies, today announced the closing of its approximately $45 million Series B financing led by the ...